NJSZDYRANKTYPO-SANMLTNESA-O
C32H24F9N3O4 — CID 156510811
Data last refreshed: (MolForge compound catalog, from PubChem)
About NJSZDYRANKTYPO-SANMLTNESA-O
NJSZDYRANKTYPO-SANMLTNESA-O (PubChem CID 156510811) has the molecular formula C32H24F9N3O4 and a molecular weight of 685.54 g/mol. Its IUPAC name is 4-[5-[4-[(4S)-4-[3,5-bis(trifluoromethyl)phenyl]-4-hydroxy-2-iminobutyl]-6-(trifluoromethyl)-3-pyridinyl]-6-methoxy-3-pyridinyl]-3-methylbenzoic acid.
Molecular Properties
| Compound Name | NJSZDYRANKTYPO-SANMLTNESA-O |
|---|---|
| PubChem CID | 156510811 |
| Molecular Formula | C32H24F9N3O4 |
| Molecular Weight | 685.54 g/mol |
| Exact Mass | 685.16 |
| IUPAC Name | 4-[5-[4-[(4S)-4-[3,5-bis(trifluoromethyl)phenyl]-4-hydroxy-2-iminobutyl]-6-(trifluoromethyl)-3-pyridinyl]-6-methoxy-3-pyridinyl]-3-methylbenzoic acid |
| SMILES | [H]/N=C(\Cc1cc(C(F)(F)F)ncc1-c1cc(-c2ccc(C(=O)O)cc2C)cnc1OC)C[C@H](O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1 |
| InChI | InChI=1S/C32H24F9N3O4/c1-15-5-16(29(46)47)3-4-23(15)19-9-24(28(48-2)44-13-19)25-14-43-27(32(39,40)41)10-17(25)8-22(42)12-26(45)18-6-20(30(33,34)35)11-21(7-18)31(36,37)38/h3-7,9-11,13-14,26,42,45H,8,12H2,1-2H3,(H,46,47)/b42-22+/t26-/m0/s1 |
| InChIKey | NJSZDYRANKTYPO-FUKFMGBISA-N |
| XLogP | 8.57 |
| TPSA | 116.39 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 48 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 685.54 |
| LogP ≤ 5 | 8.57 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156510811 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.